Literature DB >> 3142285

Study of dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum.

J Inselburg1, R D Zhang.   

Abstract

The production of the dihydrofolate reductase-thymidylate synthase (DHFR-TS) bifunctional protein of Plasmodium falciparum was measured in the wild type, pyrimethamine sensitive strain, FCR3, and in a pyrimethamine resistant mutant, FCR3-D7, which contains a DHFR-TS gene duplication that overproduces a mutant enzyme. The DHFR-TS content in both strains began to increase significantly from the early trophozoite stage through schizogony. The DHFR-TS content in either the ring or trophozoite-schizont stage parasites remained constant for at least 9 hr in the presence of protein synthesis-inhibitory levels of cycloheximide, which suggested that the measure of enzyme accumulation was a measure of enzyme synthesis. Actinomycin D treated parasites did not accumulate DHFR-TS which suggested that the DHFR-TS mRNA had a short half-life. DHFR-TS accumulated in the presence of aphidicolin inhibition of DNA synthesis which indicated that both syntheses could be uncoupled.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142285     DOI: 10.4269/ajtmh.1988.39.328

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  Cloning, expression, and characterization of Babesia gibsoni dihydrofolate reductase-thymidylate synthase: inhibitory effect of antifolates on its catalytic activity and parasite proliferation.

Authors:  Gabriel O Aboge; Honglin Jia; Mohamad A Terkawi; Youn-Kyoung Goo; Yoshifumi Nishikawa; Fujiko Sunaga; Kuzuhiko Namikawa; Naotoshi Tsuji; Ikuo Igarashi; Hiroshi Suzuki; Kozo Fujisaki; Xuenan Xuan
Journal:  Antimicrob Agents Chemother       Date:  2008-09-15       Impact factor: 5.191

2.  Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum.

Authors:  Michael Alifrangis; Inge T Christensen; Flemming S Jørgensen; Anita M Rønn; Jimmy E Weng; Ming Chen; Ib C Bygbjerg; Worachart Sirawaraporn; Yaseelan Palarasah; Claus Koch
Journal:  Malar J       Date:  2004-06-12       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.